Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classement en actions #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Prix de l'action
$0.17616661
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$73.48M
Changement (1 jour)
0.18%
Changement (1 an)
-37.76%
Pays
TW
Échange Mercury Biopharmaceutical Corporation (6932)

Catégorie

Historique du prix de l'action pour Mercury Biopharmaceutical Corporation (6932)
Prix de clôture le plus élevé : $0.19 le 2026-08-01

Prix de clôture le plus bas : $0.35 le 2022-12-01
Historique du prix de l'action de Mercury Biopharmaceutical Corporation de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -18.88%
2025 -28.11%
2024 -33.04%
2023 75.06%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN